Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
ROUGIER, Nicolas
Inria Bordeaux - Sud-Ouest
Institut des Maladies Neurodégénératives [Bordeaux] [IMN]
Inria Bordeaux - Sud-Ouest
Institut des Maladies Neurodégénératives [Bordeaux] [IMN]
LESTE-LASSERRE, Thierry
Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
< Réduire
Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
Langue
EN
Article de revue
Ce document a été publié dans
Science Advances. 2020-05-13, vol. 6, n° 20
Résumé en anglais
Dopaminergic neuronal cell death, associated with intracellular α-synuclein (α-syn)-rich protein aggregates [termed "Lewy bodies" (LBs)], is a well-established characteristic of Parkinson's disease (PD). Much evidence, ...Lire la suite >
Dopaminergic neuronal cell death, associated with intracellular α-synuclein (α-syn)-rich protein aggregates [termed "Lewy bodies" (LBs)], is a well-established characteristic of Parkinson's disease (PD). Much evidence, accumulated from multiple experimental models, has suggested that α-syn plays a role in PD pathogenesis, not only as a trigger of pathology but also as a mediator of disease progression through pathological spreading. Here, we have used a machine learning-based approach to identify unique signatures of neurodegeneration in monkeys induced by distinct α-syn pathogenic structures derived from patients with PD. Unexpectedly, our results show that, in nonhuman primates, a small amount of singular α-syn aggregates is as toxic as larger amyloid fibrils present in the LBs, thus reinforcing the need for preclinical research in this species. Furthermore, our results provide evidence supporting the true multifactorial nature of PD, as multiple causes can induce a similar outcome regarding dopaminergic neurodegeneration. © 2020 American Association for the Advancement of Science. All rights reserved.< Réduire
Mots clés en anglais
Aggregates
Cell Death
Amyloid Fibril
Disease Progression
Experimental Models
Neurodegeneration
Neuronal Cell
Non-Human Primate
Parkinson's Disease
Protein Aggregates
Mammals
Alpha Synuclein
Amyloid
Animal
Chemistry
Human
Lewy Body
Metabolism
Pathology
Primate
Animals
Humans
Lewy Bodies
Primates
Project ANR
Développment d'une infrastructure française distribuée coordonnée - ANR-10-INBS-0004
Bordeaux Region Aquitaine Initiative for Neuroscience - ANR-10-LABX-0043
Bordeaux Region Aquitaine Initiative for Neuroscience - ANR-10-LABX-0043